Cyclerion Therapeutics (CYCN) Earnings Date & Reports

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CYCN is expected to report earnings to rise 75.00% to -28 cents per share on August 08

Cyclerion Therapeutics CYCN Stock Earnings Reports

Q2'23

Est.

$-0.28

Q1'23

Beat

by $0.14

Q4'22

Beat

by $0.12

Q3'22

Beat

by $5.96

Q2'22

Missed

by $0.01

The last earnings report on May 11 showed earnings per share of -15 cents, beating the estimate of -30 cents. With 2.81K shares outstanding, the current market capitalization sits at 7.00M.

View a ticker or compare two or three

Compare

CYCN